IL1B and focal segmental glomerulosclerosis: Whereas clear upregulation of glomerular IL-1β in both FSGS models suggests a relevant role in FSGS, IL-1β inhibition by anakinra did neither counteract selected molecular processes nor result in functional attenuation of FSGS.